AZN : Imfinzi Plus Tremelimumab Show Unprecedented Survival In 1st-line Unresectable Liver Cancer

AstraZeneca (AZN.L,AZN) said Wednesday that results from the HIMALAYA Phase III trial showed a single priming dose of tremelimumab added to Imfinzi or durvalumab demonstrated a statistically significant and clinically meaningful improvement in overall survival versus sorafenib as a 1st-line treatment for patients with unresectable hepatocellular carcinoma (HCC) who had not received prior systemic therapy and were not eligible for localised treatment.

The novel dose and schedule of Imfinzi and tremelimumab, an anti-CTLA4 antibody, is called the STRIDE regimen.

According to the company, patients treated with the STRIDE regimen experienced a 22% reduction in the risk of death versus sorafenib. Median overall survival was 16.4 months versus 13.8 for sorafenib. An estimated 31% of patients were still alive at three years versus 20% for sorafenib.

The company noted that results also showed an increase in objective response rate with the STRIDE regimen versus sorafenib. Median duration of response was 22.3 months with the STRIDE regimen versus 18.4 with sorafenib. The addition of tremelimumab to Imfinzi did not increase severe liver toxicity, and no bleeding risk was observed.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A multi-state listeria outbreak that has killed one and sickened at least 23 others has been linked to Florida -based Big Olaf Creamery brand ice cream, according to the Centers for Disease Control and Prevention or CDC. The outbreak strain has been reported from 10 states, resulting in 22 hospitalizations. One death has been reported from Illinois. Natreve, a premium wellness company, is recalling certain Vegan Protein Powder due to undeclared milk, a known allergen, the U.S. Food and Drug Administration said. The recall involves specific batches of its Vegan Protein Powder French Vanilla Wafer Sundae flavor. The impacted products are stored in 13 oz (10 servings) and 1.47lb (18 servings) white tubs. The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to
Follow RTT